Correlating the clinical actions and molecular mechanisms of general anesthetics

Purpose of review To summarize recent in-vitro and in-vivo research on molecular mechanisms of general anesthetics' actions. Recent findings Classes of general anesthetics with distinct clinical profiles appear to induce amnesia, hypnosis, and immobility via different molecular targets. Propofol, etomidate, and barbiturates produce profound amnesia and hypnosis, but weak immobility, by enhancing the activity of specific gamma-aminobutyric acid typeA receptors. In contrast, nitrous oxide, xenon, and ketamine produce analgesia, but weak hypnosis and amnesia, by inhibiting glutamate and nicotinic receptors and activating potassium ‘leak’ channels such as TREK-1. Volatile halogenated anesthetics show little selectivity for molecular targets. They act on all the channels mentioned above, and other targets such as glycine receptors and mediators of neurotransmitter release. Summary Several clinically distinct ‘anesthetic states’ are induced by different classes of drugs acting on neuronal circuits via different molecular targets. Understanding the mechanisms underlying the therapeutic and toxic actions of general anesthetics helps us reframe the ‘art’ of anesthesia into more of a ‘science’. These studies also enhance efforts to develop new drugs with improved clinical utility.

[1]  N. Franks,et al.  The TREK K2P channels and their role in general anaesthesia and neuroprotection. , 2004, Trends in pharmacological sciences.

[2]  Joseph F. Cotten,et al.  Potent Activation of the Human Tandem Pore Domain K Channel TRESK with Clinical Concentrations of Volatile Anesthetics , 2004, Anesthesia and analgesia.

[3]  E. Eger,et al.  Age, Minimum Alveolar Anesthetic Concentration, and Minimum Alveolar Anesthetic Concentration-Awake , 2001, Anesthesia and analgesia.

[4]  M. Mishina,et al.  Effect of N-methyl-d-aspartate Receptor &egr;1 Subunit Gene Disruption of the Action of General Anesthetic Drugs in Mice , 2005, Anesthesiology.

[5]  M. Fanselow,et al.  Effect of Isoflurane and Other Potent Inhaled Anesthetics on Minimum Alveolar Concentration, Learning, and the Righting Reflex in Mice Engineered to Express α1 γ-Aminobutyric Acid Type A Receptors Unresponsive to Isoflurane , 2007, Anesthesiology.

[6]  E. Eger,et al.  &bgr;3-Containing Gamma-Aminobutyric AcidA Receptors Are Not Major Targets for the Amnesic and Immobilizing Actions of Isoflurane , 2005, Anesthesia and analgesia.

[7]  J. Jakobsson,et al.  Entropy of EEG during anaesthetic induction: a comparative study with propofol or nitrous oxide as sole agent. , 2004, British journal of anaesthesia.

[8]  B. Antkowiak,et al.  General anesthetic actions in vivo strongly attenuated by a point mutation in the GABAA receptor β3 subunit , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  K. Kuizenga,et al.  Biphasic EEG changes in relation to loss of consciousness during induction with thiopental, propofol, etomidate, midazolam or sevoflurane. , 2001, British journal of anaesthesia.

[10]  D. Raines,et al.  Nonhalogenated Anesthetic Alkanes and Perhalogenated Nonimmobilizing Alkanes Inhibit &agr;4&bgr;2 Neuronal Nicotinic Acetylcholine Receptors , 2002, Anesthesia and analgesia.

[11]  J. Antognini,et al.  Exaggerated Anesthetic Requirements in the Preferentially Anesthetized Brain , 1993, Anesthesiology.

[12]  A. Gray,et al.  Volatile Anesthetics Activate the Human Tandem Pore Domain Baseline K+ Channel KCNK5 , 2000, Anesthesiology.

[13]  E. Eger,et al.  Spinal N-Methyl-d-Aspartate Receptors May Contribute to the Immobilizing Action of Isoflurane , 2003, Anesthesia and analgesia.

[14]  M. Lazdunski,et al.  TREK‐1, a K+ channel involved in neuroprotection and general anesthesia , 2004, The EMBO journal.

[15]  Loren J. Martin,et al.  α5GABAA Receptors Mediate the Amnestic But Not Sedative-Hypnotic Effects of the General Anesthetic Etomidate , 2006, The Journal of Neuroscience.

[16]  M. Fanselow,et al.  The Effect of Three Inhaled Anesthetics in Mice Harboring Mutations in the GluR6 (Kainate) Receptor Gene , 2005, Anesthesia and analgesia.

[17]  E. Eger,et al.  Spinal N-methyl-d-aspartate receptors may contribute to the immobilizing action of isoflurane. , 2003 .

[18]  B. Antkowiak,et al.  Molecular and systemic mechanisms of general anaesthesia: the ‘multi-site and multiple mechanisms’ concept , 2005, Current opinion in anaesthesiology.

[19]  P. Flood,et al.  Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes. , 2001, British journal of pharmacology.

[20]  E. Eger,et al.  Mutation of KCNK5 or Kir3.2 Potassium Channels in Mice Does Not Change Minimum Alveolar Anesthetic Concentration , 2003, Anesthesia and analgesia.

[21]  D. Raines,et al.  Molecular Properties Important for Inhaled Anesthetic Action on Human 5-HT3A Receptors , 2005, Anesthesia and analgesia.

[22]  E. Eger,et al.  Glycine receptors mediate part of the immobility produced by inhaled anesthetics. , 2003, Anesthesia and analgesia.

[23]  K. Sillar,et al.  The in vitro and in vivo enantioselectivity of etomidate implicates the GABAA receptor in general anaesthesia , 2003, Neuropharmacology.

[24]  J. Olney,et al.  Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin , 1998, Nature Medicine.

[25]  E. Eger,et al.  Gamma-Aminobutyric AcidA Receptors Do Not Mediate the Immobility Produced by Isoflurane , 2004, Anesthesia and analgesia.

[26]  Z. Bosnjak,et al.  Intracellular Mechanism of Mitochondrial Adenosine Triphosphate-Sensitive Potassium Channel Activation with Isoflurane , 2003, Anesthesia and analgesia.

[27]  K Suwa,et al.  Bispectral analysis of the electroencephalogram does not predict responsiveness to verbal command in patients emerging from xenon anaesthesia. , 2000, British journal of anaesthesia.

[28]  B. Urban,et al.  Stereospecific interaction of ketamine with nicotinic acetylcholine receptors in human sympathetic ganglion-like SH-SY5Y cells. , 2000, Anesthesiology.

[29]  M. Arras,et al.  Identification of a Molecular Target Mediating the General Anesthetic Actions of Pentobarbital , 2007, Molecular Pharmacology.

[30]  A. Roch,et al.  Halothane Directly Modifies Na+ and K+ Channel Activities in Cultured Human Alveolar Epithelial Cells , 2006, Molecular Pharmacology.

[31]  D. Raines,et al.  Nonhalogenated Anesthetic Alkanes and Perhalogenated Nonimmobilizing Alkanes Inhibit α4β2 Neuronal Nicotinic Acetylcholine Receptors , 2002 .

[32]  D. Bayliss,et al.  HCN Subunit-Specific and cAMP-Modulated Effects of Anesthetics on Neuronal Pacemaker Currents , 2005, The Journal of Neuroscience.

[33]  R. Dickinson,et al.  How does xenon produce anaesthesia? , 1998, Nature.

[34]  J. Falck,et al.  The general anesthetic propofol increases brain N‐arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase , 2003, British journal of pharmacology.

[35]  T. Yamakura,et al.  Effects of Gaseous Anesthetics Nitrous Oxide and Xenon on Ligand-gated Ion Channels: Comparison with Isoflurane and Ethanol , 2000, Anesthesiology.

[36]  E. Eger,et al.  Differential Modulation of Human N-Methyl-d-Aspartate Receptors by Structurally Diverse General Anesthetics , 2006, Anesthesia and analgesia.

[37]  L. Firestone,et al.  Anesthesia Sensitivity in Mice that Lack the β3 Subunit of the γ-Aminobutyric Acid Type A Receptor , 1998 .

[38]  E. Eger,et al.  Hexafluorobenzene Acts in the Spinal Cord, Whereas O-Difluorobenzene Acts in Both Brain and Spinal Cord, to Produce Immobility , 2007, Anesthesia and analgesia.

[39]  L. Firestone,et al.  Anesthesia Sensitivity in Mice that Lack the beta 3 Subunit of the gamma‐Aminobutyric Acid Type A Receptor , 1998, Anesthesiology.

[40]  E. Eger,et al.  Acetylcholine receptors do not mediate the immobilization produced by inhaled anesthetics. , 2002 .

[41]  A. McEwan,et al.  The Interaction of Fentanyl on the Cp50 of Propofol for Loss of Consciousness and Skin Incision , 1994, Anesthesiology.

[42]  R. Olsen,et al.  Identification of a GABAA Receptor Anesthetic Binding Site at Subunit Interfaces by Photolabeling with an Etomidate Analog , 2006, The Journal of Neuroscience.

[43]  D. Swandulla,et al.  Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. , 1992, European journal of pharmacology.

[44]  Marc Lemaire,et al.  Protein crystallography under xenon and nitrous oxide pressure: comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action. , 2007, Biophysical journal.

[45]  M. Mishina,et al.  Chronopharmacological studies of ketamine in normal and NMDA Ε1 receptor knockout mice , 2004 .

[46]  P. Flood,et al.  Neuronal nicotinic acetylcholine receptor modulation by general anesthetics. , 1998, Toxicology letters.

[47]  C. Crowder,et al.  Xenon Acts by Inhibition of Non–N-methyl-d-aspartate Receptor–mediated Glutamatergic Neurotransmission in Caenorhabditis elegans , 2005, Anesthesiology.

[48]  M. Mishina,et al.  Chronopharmacological studies of ketamine in normal and NMDA epsilon1 receptor knockout mice. , 2004, British Journal of Anaesthesia.

[49]  B. Antkowiak,et al.  Anaesthetic drugs: linking molecular actions to clinical effects. , 2006, Current pharmaceutical design.

[50]  W. R. Lieb,et al.  Determinants of the Sensitivity of AMPA Receptors to Xenon , 2004, Anesthesiology.

[51]  M. Laster,et al.  GABAA Receptor Blockade Antagonizes the Immobilizing Action of Propofol but Not Ketamine or Isoflurane in a Dose-Related Manner , 2003, Anesthesia and analgesia.

[52]  P. Flood,et al.  Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant α7 and α4β2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes , 2001 .

[53]  R. Harris,et al.  Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors , 1997, Nature.

[54]  J. Scholz,et al.  Activation of &agr;2B-Adrenoceptors Mediates the Cardiovascular Effects of Etomidate , 2003 .

[55]  C. Crowder,et al.  Nitrous oxide (N(2)O) requires the N-methyl-D-aspartate receptor for its action in Caenorhabditis elegans. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[56]  E. Eger,et al.  Acetylcholine Receptors Do Not Mediate the Immobilization Produced by Inhaled Anesthetics , 2002, Anesthesia and analgesia.

[57]  D. Raines,et al.  Nonhalogenated Alkane Anesthetics Fail to Potentiate Agonist Actions on Two Ligand-gated Ion Channels , 2001, Anesthesiology.

[58]  G. Dawson,et al.  Sedation and Anesthesia Mediated by Distinct GABAA Receptor Isoforms , 2003, The Journal of Neuroscience.

[59]  P. Whiting,et al.  The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[60]  E. Eger,et al.  Neither GABAA nor Strychnine-Sensitive Glycine Receptors Are the Sole Mediators of MAC for Isoflurane , 2001, Anesthesia and analgesia.